HomeInsightsPE

Granules India Ltd PE Ratio

Granules India Ltd PE Ratio

stocks purchased

₹ 3.3 Cr

Volume transacted

stocks purchased

60.1 K

stocks traded

Last Updated time: 19 Sep 10:27 AM

Image

Granules India Ltd

NSE: GRANULES

PE

27

Last updated: 19 Sep 10:27 AM

Key Highlights

  • The P/E Ratio of Granules India Ltd is 27 as of 19 Sep 10:27 AM.
  • The P/E Ratio of Granules India Ltd changed from 12.3 on March 2019 to 25.7 on March 2024 . This represents a CAGR of 13.07% over 6 years. .
  • The Latest Trading Price of Granules India Ltd is ₹ 547.25 as of 19 Sep 10:20.
  • The PE Ratio of Pharmaceuticals Industry has changed from 28.2 to 27.1 in 5 years. This represents a CAGR of -0.79%.
  • The PE Ratio of Automobile industry is 21.8. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.2. The PE Ratio of Pharmaceuticals industry is 40.2. The PE Ratio of Retail industry is 164.1. The PE Ratio of Textiles industry is 35.8. In 2024.

Historical P/E Ratio of Granules India Ltd

No data available

Company Fundamentals for Granules India Ltd

No data available

Image

Granules India Ltd

NSE: GRANULES

PRICE

547.25

-0.35 (-0.06%)

stock direction

Last updated: 19 Sep 10:20

Share price Over Time

1M

1Y

3Y

5Y

Monitoring Granules India Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Share Price

Date
leftPriceleft
18 Sep 2024547.6
17 Sep 2024544
16 Sep 2024550.05
13 Sep 2024555.1
12 Sep 2024564.8
11 Sep 2024677.8
10 Sep 2024694.4
09 Sep 2024666.4
06 Sep 2024687.85
05 Sep 2024697.8

SWOT Analysis Of Granules India Ltd

Strength

4

S

Weakness

1

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Granules India Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Granules India Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/E Ratio

Company NamePEMarket Cap (INR Cr.)
Granules India Ltd2613,272
Sun Pharmaceuticals Industries Ltd414,39,714
Divis Laboratories Ltd861,45,166
Cipla Ltd301,33,402
Torrent Pharmaceuticals Ltd681,13,724
Dr Reddys Laboratories Ltd191,09,604

Key Valuation Metric of Granules India Ltd

No data available

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Granules India Ltd

No data available

* All values are in crore

Historical Revenue of Granules India Ltd

No data available

* All values are in crore

Historical EBITDA of Granules India Ltd

No data available

* All values are in crore

Historical Net Profit of Granules India Ltd

No data available

* All values are in crore

Historical Dividend Payout of Granules India Ltd

No data available

* All values are in %

About Granules India Ltd

  • Granules India Limited is a large-scale vertically integrated company founded in March 18th, 1991 manufacturing Active Pharmaceutical Ingredient (API), Pharmaceutical Formulation Intermediate (PFI) and Finished Dosage (FD). With a strong presence across all three vertical, the company has created a leadership position in the off-patent drugs segment along with ensuring a strong presence in first line of defense' products such as Paracetamol, Ibuprofen, Metformin and Guaifenesin.
  • The company has a global presence across over 80 countries servicing over 300 customers.
  • Granules India is the preferred supplier for some of the world's leading pharma branded and generics companies.
  • The company has one of largest PFI and single site FD facilities in the world.
  • It is also home to one of the World's largest Paracetamol API facilities.

Granules India Ltd News Hub

News

Granules India Ltd drops for fifth straight session

Granules India Ltd fell for a fifth straight session today. The stock is quoting at Rs 549...

Read more

17 Sep 202413:35

News

Granules India Ltd leads losers in 'A' group

Prism Johnson Ltd, R R Kabel Ltd, TCI Express Ltd and Raymond Ltd are among the other lose...

Read more

12 Sep 202415:00

News

Granules India tumbles after Hyderabad facility gets six observations from USFDA

'We acknowledge that several investors have sought clarification, and we want to reassure ...

Read more

12 Sep 202415:15

News

Granules India's Gagillapur FD facility completes USFDA inspection

Granules India announced the completion of USFDA inspection of its Gagillapur FD facility ...

Read more

12 Sep 202415:19

News

Granules India's Gagillapur facility completes USFDA inspection with 6 observations

The Gagillapur facility is responsible for manufacturing Finished Dosages (FDs) and Pharma...

Read more

09 Sep 202410:30

News

Granules India Ltd soars 1.63%, up for third straight session

Granules India Ltd rose for a third straight session today. The stock is quoting at Rs 686...

Read more

21 Aug 202413:05

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

FAQs for PE of Granules India Ltd

What is the current PE Ratio of Granules India Ltd?

The Current PE Ratio of Granules India Ltd is 26.98 as on 19 Sep 2024.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.2 as on 19 Sep 2024.

What was the PE Ratio of Granules India Ltd last year?

The PE Ratio of Granules India Ltd was 13.62 last year, now the PE ratio is 26.98, showing a year-on-year growth of 98.1%.

What does the PE Ratio of Granules India Ltd indicate about its stock?

The PE Ratio of Granules India Ltd is 26.98. This ratio indicates that investors are willing to pay 26.98 times the earnings per share for each share of Granules India Ltd.

What is the PE Ratio Growth of Granules India Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Granules India Ltd grew by 98.1% whereas, the EPS ratio grew by 3.9.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*